Suchergebnisse - Eric D. Jacobsen

Treffer weiter einschränken
  1. 1
    Follicular lymphoma: 2023 update on diagnosis and management

    Follicular lymphoma: 2023 update on diagnosis and management von Eric D. Jacobsen

    Veröffentlicht 2022
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Follicular lymphoma: 2020 update on diagnosis and management

    Follicular lymphoma: 2020 update on diagnosis and management von Arnold S. Freedman, Eric D. Jacobsen

    Veröffentlicht 2019
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Rosai–Dorfman Disease with Activating <i>KRAS</i> Mutation — Response to Cobimetinib

    Rosai–Dorfman Disease with Activating <i>KRAS</i> Mutation — Response to Cobimetinib von Eric D. Jacobsen, Vignesh Shanmugam, Jyothi P. Jagannathan

    Veröffentlicht 2017
    Volltext Volltext
    Carta
    Zu den Favoriten
    Gespeichert in:
  4. 4
    2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

    2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) von Mark W. Clemens, Eric D. Jacobsen, Steven M. Horwitz

    Veröffentlicht 2019
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Concepts of Intrinsic Value and Integrity of Plants in Organic Plant Breeding and Propagation

    Concepts of Intrinsic Value and Integrity of Plants in Organic Plant Breeding and Propagation von E. Lammerts Van Bueren, P.C. Struik, M. Tiemens‐Hulscher, Eric D. Jacobsen

    Veröffentlicht 2003
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Increased Risk of Infectious Complications in Older Patients With Indolent Non-Hodgkin Lymphoma Exposed to Bendamustine

    Increased Risk of Infectious Complications in Older Patients With Indolent Non-Hodgkin Lymphoma Exposed to Bendamustine von Monica Fung, Eric D. Jacobsen, Arnold S. Freedman, Daniel Prestes, Dimitrios Farmakiotis, Xiangmei Gu, Paul L. Nguyen, Sophia Koo

    Veröffentlicht 2018
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma

    Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma von Vignesh Shanmugam, Gabriel K. Griffin, Eric D. Jacobsen, Christopher D.�M. Fletcher, Lynette M. Sholl, Jason L. Hornick

    Veröffentlicht 2019
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma

    Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma von Michael Crump, Bertrand Coiffier, Eric D. Jacobsen, Linda Sun, Justin L. Ricker, Huafeng Xie, Stanley R. Frankel, Sophia Randolph, Bruce D. Cheson

    Veröffentlicht 2008
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin

    Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin von Steven M. Horwitz, Ranjana H. Advani, Nancy L. Bartlett, Eric D. Jacobsen, Jeff P. Sharman, Owen A. O’Connor, Tanya Siddiqi, Dana A. Kennedy, Yasuhiro Oki

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome

    A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome von Eric D. Jacobsen, H. T. Kim, Vincent T. Ho, Corey Cutler, John Koreth, David C. Fisher, Philippe Armand, Edwin P. Alyea, Arnold S. Freedman, RJ Soiffer, Joseph H. Antin

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

    Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimul... von John F. DiPersio, Ivana N. Micallef, Patrick J. Stiff, Brian J. Bolwell, Richard T. Maziarz, Eric D. Jacobsen, Auayporn Nademanee, John M. McCarty, Gary Bridger, Gary Calandra

    Veröffentlicht 2009
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma

    Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma von Deepa Jagadeesh, Steve Horwitz, Nancy L. Bartlett, Hyun Soo Kim, Eric D. Jacobsen, Madeleine Duvic, Meredith Little, William L. Trepicchio, Keenan Fenton, Matthew Onsum, Julie Lisano, Ranjana H. Advani

    Veröffentlicht 2022
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Prognostic factors for patients with diffuse large <scp>B</scp> cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era

    Prognostic factors for patients with diffuse large <scp>B</scp> cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emis... von Philippe Armand, Sarah A. Welch, Haesook T. Kim, Ann S. LaCasce, Eric D. Jacobsen, Matthew S. Davids, Caron A. Jacobson, David C. Fisher, Jennifer R. Brown, Erin Coughlin, Arnold S. Freedman, Yi‐Bin Chen

    Veröffentlicht 2012
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

    Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma von Jeffrey A. Barnes, Eric D. Jacobsen, Yang Feng, AS Freedman, Ephraim P. Hochberg, Ann S. LaCasce, Philippe Armand, Robin Joyce, Aliyah R. Sohani, Scott J. Rodig, Donna Neuberg, David C. Fisher, Jeremy S. Abramson

    Veröffentlicht 2012
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression

    Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression von Eric D. Jacobsen, Jeff P. Sharman, Yasuhiro Oki, Ranjana H. Advani, Jane N. Winter, Celeste M. Bello, Gary Spitzer, Maria Corinna Palanca-Wessels, Dana A. Kennedy, Pamela Levine, Jing Yang, Nancy L. Bartlett

    Veröffentlicht 2015
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    Ventricular arrhythmias and sudden death in patients taking ibrutinib

    Ventricular arrhythmias and sudden death in patients taking ibrutinib von Benjamin L. Lampson, Lijian Yu, Robert J. Glynn, Jacqueline C. Barrientos, Eric D. Jacobsen, Versha Banerji, Jeffrey A. Jones, Renata Walewska, Kerry J. Savage, Gregory F. Michaud, Javid J. Moslehi, Jennifer R. Brown

    Veröffentlicht 2017
    Volltext Volltext
    Carta
    Zu den Favoriten
    Gespeichert in:
  17. 17
    A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

    A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma von Thomas E. Witzig, Craig B. Reeder, Betsy LaPlant, Mamta Gupta, Patrick B. Johnston, Ivana N. Micallef, Luis F. Porrata, Stephen M. Ansell, Joseph P. Colgan, Eric D. Jacobsen, Irene M. Ghobrial, Thomas M. Habermann

    Veröffentlicht 2010
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome

    Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome von Philippe Armand, Haesook T. Kim, Vincent T. Ho, Corey Cutler, John Koreth, Joseph H. Antin, Ann S. LaCasce, Eric D. Jacobsen, David C. Fisher, Jennifer R. Brown, George P. Canellos, Arnold S. Freedman, Robert J. Soiffer, Edwin P. Alyea

    Veröffentlicht 2008
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

    Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia von Philip C. Amrein, Eyal C. Attar, Tak Takvorian, Ephraim P. Hochberg, Karen K. Ballen, K. Leahy, David C. Fisher, Ann S. LaCasce, Eric D. Jacobsen, Philippe Armand, Robert P. Hasserjian, Lillian Werner, Donna Neuberg, Jennifer R. Brown

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    A phase 2 study of Rituximab‐Bendamustine and Rituximab‐Cytarabine for transplant‐eligible patients with mantle cell lymphoma

    A phase 2 study of Rituximab‐Bendamustine and Rituximab‐Cytarabine for transplant‐eligible patients with mantle cell lymphoma von Philippe Armand, Robert Redd, Jad Bsat, Sangeetha Mayuram, Angela Giardino, David C. Fisher, Ann S. LaCasce, Caron A. Jacobson, Matthew S. Davids, Jennifer R. Brown, Li Weng, Jennifer Wilkins, Malek Faham, Arnold S. Freedman, Robin Joyce, Eric D. Jacobsen

    Veröffentlicht 2016
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: